Goldman Sachs has reiterated its Sell rating on Colgate-Palmolive India and set a target price of ₹2,300 per share, implying a downside from the current market price of ₹2,375.90.
The brokerage highlighted that Colgate’s Q1FY26 performance was weaker than anticipated, with revenue falling 4% year-on-year. EBITDA declined 11% YoY and profit after tax (PAT) dropped 12% YoY. The pressure on margins persisted despite reduced advertising expenditure, due to a fall in gross margins.
In response to the muted performance, Goldman Sachs has trimmed its earnings estimates for FY26 and FY27 by 3–4%. The firm remains cautious on Colgate’s near-term profitability and sees limited triggers for a re-rating.
Disclaimer: The brokerage views expressed above are those of Goldman Sachs. This article does not constitute investment advice. Readers are advised to consult their financial advisor before making any investment decisions.
